港股異動| 華虹半導體(1347.HK)漲近5% 獲券商唱好
格隆匯11月18日丨華虹半導體(1347.HK)持續拉昇,現報32.65港元,漲幅4.98%,最新總市值423億港元。方正證券指,公司是大陸特色工藝代工龍頭,受惠於功率半導體及CIS高景氣,8寸持續滿載,12寸擴產順利。預計公司2020-2022年實現收入9.50/12.00/13.89億美元,重申“強烈推薦”評級。野村指,公司三季度銷售額與毛利率分別為2.53億美元與24.2%,明顯超出其業績指引,由於華虹目前的估值依舊處於較為合理的區間,我們維持對其的中性評級,並保持33港元的目標價不變。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.